References
- Tsai CH, Ogawa R. Keloid research: current status and future directions. Scars Burns Heal. 2019;5:1–8.
- Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. IJMS. 2017; 18(3):606.
- Ningsih SS, Sari DH, Antarianto RD, Hardiany NS, et al. Expressions of stemness markers in keloid tissue. Med J Indones. 2018; 27(3):145–149.
- Mufti ST, Moshref SS. Keloid and hypertrophic scars: comparative histopathological and immunohistochemical study. J King Abdulaziz Uni: Med Sci. 2010;98(279):1–39.
- Halim AS, Emami A, Salahshourifar I, Kannan TP. Keloid scarring: understanding the genetic basis, advances, and prospects. Arch Plast Surg. 2012;39(3):184–189.
- Ud-Din S, Bayat A. New insights on keloids, hypertrophic scars, and striae. Dermatol Clin. 2014;32(2):193–209.
- Arno AI, Gauglitz GG, Barret JP, et al. Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns. 2014;40(7):1255–1266.
- Ledon JA, Savas J, Franca K, et al. Intralesional treatment for keloids and hypertrophic scars: a review. Dermatol Surg. 2013;39(12):1745–1757.
- Ogawa R, Akaishi S, Kuribayashi S, et al. Keloids and hypertrophic scars can now be cured completely: recent progress in our understanding of the pathogenesis of keloids and hypertrophic scars and the most promising current therapeutic strategy. J Nippon Med Sch. 2016; 83(2):46–53.
- Smith OJ, McGrouther DA. The natural history and spontaneous resolution of keloid scars. J Plast Reconstr Aesthet Surg. 2014;67(1):87–92.
- Nicholas RS, Falvey H, Lemonas P, et al. Patient-related keloid scar assessment and outcome measures. Plastic Reconstruct Surg. 2012;129(3):648–656.
- Wong T-S, Li JZ-H, Chen S, et al. The efficacy of triamcinolone acetonide in keloid treatment: a systematic review and meta-analysis. Front Med. 2016;3:71.
- Trisliana Perdanasari A, Lazzeri D, Su W, et al. Recent developments in the use of intralesional injections keloid treatment. Arch Plast Surg. 2014;41(6):620–629.
- Hayashi T, Furukawa H, Oyama A, et al. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. Dermatol Surg. 2012;38(6):893–897.
- Robles DT, Moore E, Draznin M, et al. Keloids: patho-physiology and management. Dermatol Online J. 2007;13(3):9.
- Huang L, Cai YJ, Lung I, et al. A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro. J Plast Reconstr Aesthet Surg. 2013;66(9):e251–9.
- Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg. 2006;8(6):362–368.
- Al Aradi IK, Alawadhi SA, Alkhawaja FA, et al. Earlobe keloids: a pilot study of the efficacy of keloidectomy with core fillet flap and adjuvant intralesional corticosteroids. Dermatol Surg. 2013;39(10):1514–1519.
- Muneuchi G, Suzuki S, Onodera M, et al. Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg. 2006;40(2):111–116.
- Rahban S, Garner W. Fibroproliferative scars. Clin Plast Surg. 2003; 30(1):77–89.
- Acosta S, Ureta E, Yanez R, et al. Effectiveness of intralesional triamcinolone in the treatment of keloids in children. Pediatr Dermatol. 2016;33(1):75–79.
- Darzi MA, Chowdri NA, Kaul SK, et al. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg. 1992;45(5):374–379.
- Copcu E, Sivrioglu N, Oztan Y. Combination of surgery and intralesional verapamil injection in the treatment of the keloid. J Burn Care Rehabil. 2004;25(1)1–7.
- D'Andrea F, Brongo S, Ferraro G, et al. Prevention and treatment of keloids with intralesional verapamil. Dermatology. 2002;204(1):60–62.
- Lawrence WT. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg. 1996;37(2):167–169.
- Margaret Shanthi FX, Ernest K, Dhanraj P. Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol. 2008; 74(4):343–348.
- Ahuja RB, Chatterjee P. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. Burns. 2014;40(4):583–588.
- Shah VV, Aldahan AS, Mlacker S, et al. 5-Fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature. Dermatol Ther. 2016;6(2):169–183.
- Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol. 2005;52(3 Pt 1):474–479.
- Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg. 2004;30(1):54–56.
- Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006;32(7):907–915.
- Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or incombination with 5-fluorouracil for the treatment of keloid and hypertrophicscars. Clin Exp Dermatol. 2009;34(2):219–223.
- Haurani MJ, Foreman K, Yang JJ, et al. 5-Fluorouracil treatment of problematic scars. Plast Reconstr Surg. 2009;123(1):139–148.
- Sadeghinia A, Sadeghinia S. Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids. Dermatol Surg. 2012;38(1):104–109.
- Hietanen KE, Järvinen TA, Huhtala H, et al. Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections – a randomized controlled trial. J Plastic Reconstruct Aesthet Surg. 2019;72(1):4–11.
- Woo SH, Jeong HS, Kim JP, et al. Favorable vocal fold wound healing induced by platelet-rich plasma injection. Clin Exp Otorhinolaryngol. 2014; 7(1):47–52.
- Chen MA, Davidson TM. Scar management: prevention and treatment strategies. Curr Opin Otolaryngol Head Neck Surg. 2005; 13(4):242–247.
- Klosová H, Stětinský J, Bryjová I, et al. Objective evaluation of the effect of autologous platelet concentrate on post-operative scarring in deep burns. Burns. 2013; 39(6):1263–1276.
- Obolenskiy VN, Ermolova DA, Laberko LA, et al. Efficacy of platelet rich plasma for the treatment of chronic wounds. EWMA Journal. 2014;14(1):37–41.
- Hersant B, SidAhmed-Mezi M, Picard F, et al. Efficacy of autologous platelet concentrates as adjuvant therapy to surgical excision in the treatment of keloid scars refractory to conventional treatments: a pilot prospective study. Ann Plast Surg. 2018;81(2):170–175.
- Jones ME, Hardy C, Ridgway J. Keloid management: a retrospective case review on a new approach using surgical excision, platelet-rich plasma, and in-office superficial photon X-ray radiation therapy. Adv Skin Wound Care. 2016;29(7):303–307.
- Azzam EZ, Omar SS. Treatment of auricular keloids by triple combination therapy: surgical excision, platelet‐rich plasma, and cryosurgery. J Cosmet Dermatol. 2018;17(3):502–510.
- Hewedy ES, Sabaa BEI, Mohamed WS, et al. Combined intralesional triamcinolone acetonide and platelet rich plasma versus intralesional triamcinolone acetonide alone in treatment of keloids. J Dermatol Treat. 2020;25(9):1–7.